ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adames, VR; Heathers, GP; Higgins, AJ; Su, CM | 1 |
| Corr, PB; Creer, MH; Saffitz, JE; Sobel, BE; Yamada, KA | 1 |
2 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Ventricular Fibrillation
| Article | Year |
|---|---|
Reperfusion-induced accumulation of long-chain acylcarnitines in previously ischemic myocardium.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Epoxy Compounds; Male; Molecular Weight; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 1993 |
Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
Topics: Acyltransferases; Animals; Blood Flow Velocity; Carnitine; Carnitine Acyltransferases; Cats; Chromatography, High Pressure Liquid; Coronary Circulation; Coronary Disease; Coronary Vessels; Epoxy Compounds; Ethers, Cyclic; Fatty Acids; Hemodynamics; Kinetics; Lysophosphatidylcholines; Myocardium; Ventricular Fibrillation | 1989 |